Our privacy policy describes how Fidessa uses cookies on our website. If you continue using our website, you are consenting to our use of cookies. OK

Fragulation Fever

Firstly thanks to everyone who has emailed me with such positive responses to the Fragulator. Thousands of fragulations have taken place on the site since Friday and it’s great to know that so many of you are finding it useful.

We’ve had all sorts of interesting feedback, especially in terms of the classifications we have chosen and the different levels of reporting transparency. A full guide to the different trade types can be found on the FAQ page but basically we still classify a trade as lit provided that at least one side came from a lit order book. So, for example, a dark order that interacts with a lit order is still classified as a lit trade. You can see this in the Fragulator tables which separate out dark to dark interactions at Chi-Delta or Turquoise from other trades in their lit books.

The bigger issue, though, is one of transparency and the fact that dark and other non-lit venues observe completely different levels of transparency. The activities of the big broker dark pools have especially come in for some stick in this area and I know that the primary exchanges are crying foul at the regulators over this. Basically, their view is that if you act like an exchange (i.e. by matching orders), then you should have to report like an exchange. The risk they claim is that, without a level playing field, transparency goes down and Europe potentially becomes a dealer market – neither of which were the intended consequences of MiFID. On the other hand, the brokers claim that they are providing a very necessary liquidity operation by allowing traders to interact in their dark pools in different ways. It all seems like the next chapter in a subtle power play between the big exchanges on one side and the big banks and brokers on the other.

Meanwhile, the folks at CESR are getting lobbied from all sides on what is best for the market. For more information on this you might want to look at FT Trading room which features a video interview with a certain shiny headed industry observer.

It seems certain, though, that more regulation is on the way. With this in mind it’s interesting to note the sudden outbreak of accord between the LSE and the big banks over Turquoise. Maybe it’s recognition that these participants would rather sort out their own issues than have the regulators do it for them.

Comments
One Response to “Fragulation Fever”
  1. John, EC2 says:

    The FT reported on Monday that the London Investment Banking Association had published a paper on this. The full text of the paper can be found here:
    http://www.liba.org.uk/issues/2009/Oct/MIFID%20equity%20markets%20briefing%20paper%202.10%20final.pdf

Leave a comment

Copyright © 2018 Fidessa Group Holdings Limited. All rights reserved.

The information contained within this website is provided for informational purposes only. Fidessa will use reasonable care to ensure that information is accurate at the time it is made available, and for the duration that it remains on the site. The information may be changed by Fidessa at any time without notice. We also reserve the right to close the website at any time. No representation or warranty, expressed or implied, is given on behalf of Fidessa or any of its respective directors, employees, agents, or advisers as to the accuracy or completeness of the information or opinions contained herein or its suitability for any purpose and, save in the case of fraud, all liability for direct, indirect, special, consequential or other loss or damages of whatever kind that may arise from use of the website is hereby excluded to the fullest extent permitted by law. Any decisions you make based on the information in this website are your sole responsibility and information on the website should not be relied upon in connection with any investment decision.

The copyright of this website belongs to Fidessa. All other intellectual property rights are reserved.

Fragulator® is a registered trademark of Fidessa Group Holdings Limited.

Reproduction or redistribution of this information is prohibited except with written permission from Fidessa.